Proton therapy developer Ion Beam Applications (IBA) posted revenue increases for its first half of 2017.
For the period (end-June 30), total revenues increased 4.5% to 152 million euros ($179.2 million U.S.), compared with 145 million euros ($171 million) for the same period in 2016. The company's sales of proton therapy and accelerators increased by 1.7% to 123 million euros ($145 million), while its dosimetry business segment increased by 18.7% to 28.4 million euros ($33.5 million).
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
